Yahoo
Toronto - Delayed Quote CAD

CareRx Corporation (CRRX.TO)

3.3700 +0.0500 (+1.51%)
At close: October 30 at 3:59:59 PM EDT
Chart Range Bar
Loading chart for CRRX.TO
  • Previous Close 3.3200
  • Open 3.3200
  • Bid 3.3500 x --
  • Ask 3.3900 x --
  • Day's Range 3.3200 - 3.3900
  • 52 Week Range 3.1000 - 4.0000
  • Volume 19,344
  • Avg. Volume 32,262
  • Market Cap (intraday) 213.758M
  • Beta (5Y Monthly) 0.47
  • PE Ratio (TTM) 8.22
  • EPS (TTM) 0.4100
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield 0.09 (2.61%)
  • Ex-Dividend Date Sep 15, 2026
  • 1y Target Est 5.14

CareRx Corporation, together with its subsidiaries, provides pharmacy services to senior homes and other congregate care settings in Canada. The company also offers medication management services. It serves long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is based in Toronto, Canada.

www.carerx.ca

1,433

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CRRX.TO
9.92%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

CRRX.TO
3.63%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

CRRX.TO
122.40%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

CRRX.TO
29.05%
S&P/TSX Composite index (^GSPTSE)
69.32%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 93.92M
Earnings --
Profit Margin 0.00%

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

0
20M
40M
60M
80M
0.0%

Analyst Insights

View More

Analyst Price Targets

4.25
5.14 Average
3.3700 Current
6.25 High

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.13%

  • Return on Assets (ttm)

    3.34%

  • Return on Equity (ttm)

    27.34%

  • Revenue (ttm)

    376.8M

  • Net Income Avi to Common (ttm)

    26.87M

  • Diluted EPS (ttm)

    0.4100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.57M

  • Total Debt/Equity (mrq)

    69.65%

  • Levered Free Cash Flow (ttm)

    16.52M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: